Prevention of HPV in the School Health Service

Not Applicable

Completed

• Conditions: Human Papillomavirus; Cervix Cancer

• Registration Number: NCT02280967
• Lead Sponsor: Uppsala University

Brief Summary

The last ten years sexually transmitted infections (STI) have substantially increased among adolescents. STI can lead to individual suffering and have a negative effect on the future reproductive health and also increase the need for health care, thus it is important to reduce the number of STIs. HPV vaccination is included in the school-based vaccination program since 2012, a catch-up vaccination is offered to older girls and young women aged 13-25. School nurses have a key role regarding information about HPV and HPV vaccine, and the school-based vaccination program has a substantial higher coverage rate. Knowledge is an important factor associated with attitude to preventive methods against HPV. In previous studies the results indicate that young people have low awareness of HPV and the HPV vaccine. Interventions can decrease sexual risk taking and influence the intention to receive HPV vaccination and increase the use of condom.

The aim of this study is to increase primary prevention of human papillomavirus (HPV) by promoting HPV vaccination and increase condom use among upper secondary students. The aim is also to increase the knowledge about HPV, risk and prevention.

Detailed Description

Not available

Study Timeline

• Study Start: 2014-01
• Study First Submitted: 2014-10-21
• Study First Submitted QC: 2014-10-29
• Study First Posted: 2014-11-02
• Primary Completion: 2017-08
• Study Completion: 2017-08-01
• Status Verified: 2017-09
• Last Update Submitted: 2017-09-01
• Last Update Posted: 2017-09-05

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 832

Inclusion Criteria

• First year students in upper secondary school who visit the school nurse for the regular health interview.
• Master Swedish in speech and writing.

Exclusion Criteria

• Students with cognitive disabilities.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Attitude to prevention about HPV	Change from Baseline Attitude at 24 months	Attitude to HPV vaccine. Intention to be vaccinated against HPV. Condom use and intention to attend future cervical cancer screening programmes. Measured by questionnaire, five-point Likert scale ranging from "totally agree" to "totally disagree".
Intention to use condom if new partner	Change from Baseline Intention at 24 months	Intention to use condom if new partner measured by questionnaire, five-point Likert scale ranging from "totally agree" to "totally disagree".

Secondary Outcome Measures

Name	Time	Method
Behavioural outcomes: Increased HPV vaccination and increased condom use.	Change from Baseline Behaviour at 24 months.	Measured by questionnaire. Vaccinated against HPV? Condom use at last sexual intercourse?

Trial Locations

Locations (1)

Uppsala University, Public Health and Caring Sciences; 🇸🇪 Uppsala, Sweden